Development of a mantle cell lymphoma in an ATM heterozygous woman after occupational exposure to ionising radiation and somatic mutation of the second allele

Leukemia Research

Volumn 30, Issue 9, 2006, Pages 1193-1196

  Briani, Chiara ^a   Schlotter, Magdalena ^b   Lichter, Peter ^b   Kalla, Claudia ^b  

^a UNIVERSITY OF PADOVA   (Italy)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

ATM; Ionising radiation; Mantle cell lymphoma; Predisposition of heterozygotes; Somatic mutation

Indexed keywords

ANTINEOPLASTIC AGENT; ATM PROTEIN;

ADULT; ALLELE; ARTICLE; ATM GENE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SUSCEPTIBILITY; CASE REPORT; FAMILY HISTORY; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE; GENE DELETION; GENETIC SUSCEPTIBILITY; HETEROZYGOTE; HUMAN; HUMAN TISSUE; INTESTINE LYMPHOMA; IONIZING RADIATION; LABORATORY TEST; LONG TERM EXPOSURE; MANTLE CELL LYMPHOMA; MUTATIONAL ANALYSIS; OCCUPATIONAL EXPOSURE; PRIORITY JOURNAL; RADIATION CARCINOGENESIS; RADIATION EXPOSURE; RADIOLOGIST; SOMATIC MUTATION;

ALLELES; CELL CYCLE PROTEINS; DNA-BINDING PROTEINS; FEMALE; GENES, TUMOR SUPPRESSOR; HETEROZYGOTE; HUMANS; LYMPHOMA, MANTLE-CELL; MALE; MIDDLE AGED; MUTATION; NEOPLASMS, RADIATION-INDUCED; OCCUPATIONAL EXPOSURE; PEDIGREE; PROTEIN-SERINE-THREONINE KINASES; RADIATION, IONIZING; RADIOLOGY; TUMOR SUPPRESSOR PROTEINS;

EID: 33745867256     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2005.11.010     Document Type: Article

References (12)

1. Rotman G., and Shiloh Y. ATM: from gene to function. Hum Mol Genet 7 (1998) 1555-1563
2. Taylor A.M.R., Metcalfe J.A., Thick J., and Mak Y.-F. Leukemia and lymphoma in ataxia telangiectasia. Blood 87 (1996) 423-438
3. Barlow C., Hirotsune S., Paylor R., Liyanage M., Eckhaus M., Collins F., et al. ATM-deficient mice: a paradigm of ataxia telangiectasia. Cell 86 (1996) 159-171
4. Gumy-Pause F., Wacker P., and Sappino A.P. ATM gene and lymphoid malignancies. Leukemia 18 (2004) 238-242
5. Morrell D., Cromartie E., and Swift M. Mortality and cancer incidence in 263 patients with ataxia-telangiectasia. J Natl Cancer Inst 77 (1986) 89-92
6. Swift M., Morrell D., Massey R.B., and Chase C.L. Incidence of cancer in 161 families affected by ataxia-telangiectasia. N Engl J Med 325 (1991) 1831-1836
7. Döhner H., Stilgenbauer S., James M.R., Benner A., Weilguni T., Bentz M., et al. 11q deletions identify a new subset of B-cell chronic lymphocytic leukemia characterized by extensive nodal involvement and inferior prognosis. Blood 89 (1997) 2516-2522
8. Stilgenbauer S., Winkler D., Ott G., Schaffner C., Leupolt E., Bentz M., et al. Molecular characterization of 11q deletions points to a pathogenic role of the ATM gene in mantle cell lymphoma. Blood 94 (1999) 3262-3264
9. Schaffner C., Idler I., Stilgenbauer S., Döhner H., and Lichter P. Mantle cell lymphoma is characterized by inactivation of the ATM gene. Proc Natl Acad Sci USA 97 (2000) 2773-2778
10. Gilad S., Khosravi R., Shkedy D., Uziel T., Ziv Y., Savitsky K., et al. Predominance of null mutations in ataxia-telangiectasia. Hum Mol Genet 5 (1996) 433-439
11. Su Y., and Swift M. Mortality rates among carriers of ataxia-telangiectasia mutant alleles. Ann Intern Med 133 (2000) 770-778
12. Weil M.M., Kittrell F.S., Yu Y., McCarthy M., Zabriskie R.C., and Ullrich R.L. Radiation induces genomic instability and mammary ductal dysplasia in ATM heterozygous mice. Oncogene 20 (2001) 4409-4411